2019 - 2020
The Scopus Biopharma company funded the conduct of a feasibility study for the development of protocols for synthesis of new CBD derivatives.
Multidisciplinary Center for Cannabinoid Research
The research funds were awarded for the period of 2018-2022. Project: Stretching the Model of TRPV1 Activation.
Israel Science Foundation (ISF)
2017 - 2018
The research funds were awarded for the period of 2017-18. Project: Novel Synthetic Scaffold DT100 Promotes Silencing of the Pain Receptor TRPV1.
Ministry of Economy and Industry